Identification of prognostic factors for Krukenberg tumor
Aims: A Krukenberg tumor (KT) is an uncommon type of ovarian cancer (OC) with poor prognosis. We sought to identify prognostic factors for KT originating from primary gastrointestinal (GI) tumors. Methods: Forty-four patients with KT were assessed with follow-up. The primary endpoint was overall sur...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2013-05-01
|
| Series: | Gynecology and Minimally Invasive Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213307013000282 |
| _version_ | 1819033159033946112 |
|---|---|
| author | Weiqi Lu Lei Yuan Xishi Liu Sun-Wei Guo |
| author_facet | Weiqi Lu Lei Yuan Xishi Liu Sun-Wei Guo |
| author_sort | Weiqi Lu |
| collection | DOAJ |
| description | Aims: A Krukenberg tumor (KT) is an uncommon type of ovarian cancer (OC) with poor prognosis. We sought to identify prognostic factors for KT originating from primary gastrointestinal (GI) tumors.
Methods: Forty-four patients with KT were assessed with follow-up. The primary endpoint was overall survival (OS) after first gynecological or GI surgery.
Results: The use of postoperative chemotherapy, unilaterally involved ovarian mass, resection of primary tumors, absence of metastatic residuals, and diagnosis of GI tumors synchronously with or after gynecological surgery were identified to be prognostically favorable. For OS after the first cancer-related surgery, only the resection of primary tumor and absence of metastatic residuals were found to be favorable prognostic factors. The use of postoperative chemotherapy correlated with intraoperative intraperitoneal use of chemotherapy, but not with patients’ clinicopathological characteristics, which were not found to be associated with any factors.
Conclusion: The prognostic value of a factor depends on how survival is defined. Optimal cytoreductive surgery followed by aggressive chemotherapy may improve survival in KT patients. KT patients with unilaterally involved ovarian mass, resected primary tumors, and the absence of metastatic lesion residuals also seem to have a more favorable prognosis. |
| first_indexed | 2024-12-21T07:13:24Z |
| format | Article |
| id | doaj.art-bfbdf5f1da2e43f1b89cf9eb9e1a3780 |
| institution | Directory Open Access Journal |
| issn | 2213-3070 |
| language | English |
| last_indexed | 2024-12-21T07:13:24Z |
| publishDate | 2013-05-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Gynecology and Minimally Invasive Therapy |
| spelling | doaj.art-bfbdf5f1da2e43f1b89cf9eb9e1a37802022-12-21T19:11:56ZengWolters Kluwer Medknow PublicationsGynecology and Minimally Invasive Therapy2213-30702013-05-0122525610.1016/j.gmit.2013.02.006Identification of prognostic factors for Krukenberg tumorWeiqi Lu0Lei Yuan1Xishi Liu2Sun-Wei Guo3Institute of General Surgery, Shanghai Zhongshan Hospital, Fudan University, Shanghai, ChinaShanghai Obstetrics and Gynecology Hospital, Fudan University, Shanghai, ChinaShanghai Obstetrics and Gynecology Hospital, Fudan University, Shanghai, ChinaShanghai Obstetrics and Gynecology Hospital, Fudan University, Shanghai, ChinaAims: A Krukenberg tumor (KT) is an uncommon type of ovarian cancer (OC) with poor prognosis. We sought to identify prognostic factors for KT originating from primary gastrointestinal (GI) tumors. Methods: Forty-four patients with KT were assessed with follow-up. The primary endpoint was overall survival (OS) after first gynecological or GI surgery. Results: The use of postoperative chemotherapy, unilaterally involved ovarian mass, resection of primary tumors, absence of metastatic residuals, and diagnosis of GI tumors synchronously with or after gynecological surgery were identified to be prognostically favorable. For OS after the first cancer-related surgery, only the resection of primary tumor and absence of metastatic residuals were found to be favorable prognostic factors. The use of postoperative chemotherapy correlated with intraoperative intraperitoneal use of chemotherapy, but not with patients’ clinicopathological characteristics, which were not found to be associated with any factors. Conclusion: The prognostic value of a factor depends on how survival is defined. Optimal cytoreductive surgery followed by aggressive chemotherapy may improve survival in KT patients. KT patients with unilaterally involved ovarian mass, resected primary tumors, and the absence of metastatic lesion residuals also seem to have a more favorable prognosis.http://www.sciencedirect.com/science/article/pii/S2213307013000282ChemotherapyDiagnosisKrukenberg tumorPrognostic factorSurvival |
| spellingShingle | Weiqi Lu Lei Yuan Xishi Liu Sun-Wei Guo Identification of prognostic factors for Krukenberg tumor Gynecology and Minimally Invasive Therapy Chemotherapy Diagnosis Krukenberg tumor Prognostic factor Survival |
| title | Identification of prognostic factors for Krukenberg tumor |
| title_full | Identification of prognostic factors for Krukenberg tumor |
| title_fullStr | Identification of prognostic factors for Krukenberg tumor |
| title_full_unstemmed | Identification of prognostic factors for Krukenberg tumor |
| title_short | Identification of prognostic factors for Krukenberg tumor |
| title_sort | identification of prognostic factors for krukenberg tumor |
| topic | Chemotherapy Diagnosis Krukenberg tumor Prognostic factor Survival |
| url | http://www.sciencedirect.com/science/article/pii/S2213307013000282 |
| work_keys_str_mv | AT weiqilu identificationofprognosticfactorsforkrukenbergtumor AT leiyuan identificationofprognosticfactorsforkrukenbergtumor AT xishiliu identificationofprognosticfactorsforkrukenbergtumor AT sunweiguo identificationofprognosticfactorsforkrukenbergtumor |